Original Article

You have full text access to this OnlineOpen article

Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1†

  1. Nirupa Sachithanandan M.B.B.S.1,
  2. Robin A. Harle M.B.B.S.2,3,
  3. John R. Burgess M.D.1,4,‡,*

Article first published online: 20 DEC 2004

DOI: 10.1002/cncr.20825

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 509–515, 1 February 2005

Additional Information

How to Cite

Sachithanandan, N., Harle, R. A. and Burgess, J. R. (2005), Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer, 103: 509–515. doi: 10.1002/cncr.20825

Author Information

  1. 1

    Department of Diabetes and Endocrinology, Royal Hobart Hospital, Hobart, Tasmania, Australia

  2. 2

    Department of Radiology, Royal Hobart Hospital, Hobart, Tasmania, Australia

  3. 3

    Discipline of Surgery, University of Tasmania, Hobart, Tasmania, Australia

  4. 4

    Discipline of Medicine, University of Tasmania, Hobart, Tasmania, Australia

  1. ‡

    Fax: (011) 613 62310154

*Department of Diabetes and Endocrinology, Royal Hobart Hospital/University of Tasmania, G.P.O. Box 1061L Hobart, Tasmania 7001, AustraliaE-mail

  1. †

    Preliminary results in relation to this work were presented at the Annual Scientific Meeting of the Endocrine Society of Australia, Melbourne, Australia, September 14–17, 2003.

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 20 DEC 2004
  3. Manuscript Accepted: 21 OCT 2004
  4. Manuscript Revised: 18 OCT 2004
  5. Manuscript Received: 24 AUG 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (82K)

REFERENCES

  • 1
    Marx S, Spiegel AM, Doppman JL, Collins FS, Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med. 1998; 129: 484–494.
  • 2
    Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia type-1. Science. 1997; 276: 404–407.
  • 3
    Guru SC, Goldsmith PK, Burns AL. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA. 1998; 95: 1630–1634.
  • 4
    Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations in MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997; 6: 1169–1175.
  • 5
    Ki Wong F, Burgess J, Nordenskjold M, Larsson C, Tean Teh B. Multiple endocrine neoplasia type 1. Semin Cancer Biol. 2000; 10: 299–312.
  • 6
    Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern. J Clin Endocrinol Metab. 1996; 81: 1841–1845.
  • 7
    Burgess JR, Greenaway TM, Parameswaran V, Challis D, David R, Shepherd JJ. Enteropancreatic malignancy in multiple endocrine neoplasia type 1: risk factors and pathogenesis. Cancer. 1998; 83: 428–434.
    Direct Link:
  • 8
    Olufemi SE, Green JS, Manickam P, et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat. 1998; 11: 264–269.
    Direct Link:
  • 9
    Skogseid B, Ericksson B, Lundqvist G, et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab. 1991; 73: 281–287.
  • 10
    Shepherd JJ. The natural history of multiple endocrine neoplasia type 1: highly uncommon or highly unrecognised? Arch Surg. 1991; 126: 935–952.
  • 11
    Skogseid B, Rastad J, Oberg K. Multiple endocrine neoplasia type 1: clinical features and screening. Endocrinol Metab Clin North Am. 1994; 1: 1–18.
  • 12
    Metz DC, Jensen RT, Bale AE, et al. Multiple endocrine neoplasia type 1: clinical features and management. In: BilezekianJP, LevineMA, MarcusR, editors. The parathyroids. New York: Raven Press 1994: 591–646.
  • 13
    Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ. Cause of death in multiple endocrine neoplasia type 1. Arch Surg. 1993; 128: 683–690.
  • 14
    Rosai J, Higa E, Davie J. Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognised association. Cancer. 1972; 29: 1075–1083.
    Direct Link:
  • 15
    Teh BT, Zedenius J, Kytola S, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998; 228: 99–105.
  • 16
    Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001; 86: 5658–5671.
  • 17
    Darling TN, Skarulis MC, Steinberg SM, Marx SJ, Spiegel AM, Turner M. Multiple facial angiofibromas and collegenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997; 133: 853–857.
  • 18
    Gibril F, Chen YJ, Schrump D, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003; 88: 1066–1081.
  • 19
    Kluke MH, Mayer RJ. Carcinoid tumours. N Engl J Med. 1999; 340: 858–867.
  • 20
    Debeleko LV, Brambilla E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumours of the lung. Hum Mol Genet. 1997; 13: 2285–2290.
  • 21
    Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV. Genetics of neuroendocrine and carcinoid tumours. Endocrine Relat Cancer. 2003; 10: 437–450.
  • 22
    Burgess JR, Nord B, David R, et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1. Clin Endocrinol. 2000; 53: 205–211.
    Direct Link:
  • 23
    Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Int Med. 1998; 243: 465–470.
    Direct Link:
  • 24
    Teh BT, McArdle J, Chan SP, et al. Clinopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine. 1997; 76: 21–29.
  • 25
    Grama D, Skogseid B, Wilander E, et al. Pancreatic tumours in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg. 1992; 16: 611–618.
  • 26
    Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. N Engl J Med. 1990; 322: 723–727.
  • 27
    Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993; 20: 716–731.
  • 28
    Kwekkeboom D, Krenning EP, deJong M. Peptide receptor imaging and therapy. J Nucl Med. 2000; 41: 1704–1713.
  • 29
    Kaplan LM, Graeme-Cook FM. Weekly clinicopathological exercises: Case 9-1997: a 39-year-old woman with pernicious anaemia and a gastric mass. N Engl J Med. 1997; 336: 861–867.
  • 30
    Ahlman H, Wangberg B, Nilsson O. Growth regulation in carcinoid tumours. Endocrinol Metab Clin North Am. 1993; 22: 889–915.
  • 31
    Andreola S, Lombardi L, Audisio R, et al. A clinicopathological study of primary hepatic carcinoid tumours. Cancer. 1990; 65: 1211–1218.
    Direct Link:
  • 32
    Tomassetti P, Migliori M, Caletti G, Fusaroli P, Corinaldesi R, Gullo L Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med. 2000; 43: 551–554.
View Full Article (HTML) Get PDF (82K)